Biodol Therapeutics
PrivateLast Round
VC Round
May 21, 2024
Total Funding Raised
$5.36M
Company Overview
Biodol Therapeutics operates in Healthcare & Life Sciences and is based in Montarnaud. Its latest recorded funding round was a Series A round in August 2020.
Biodol Therapeutics is a biotechnology company that develops first-in-class compounds for the treatment of chronic pain by targeting the FLT3 receptor.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biodol Therapeutics Comparables
Compare Biodol Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latigo Biotherapeutics | 81% | |
| Halene Therapeutics | 77% | |
| Concentric Analgesics | 64% |
For institutional investors. Book with your work email.
Biodol Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 21, 2024 | ||||
| Series A | Aug 31, 2020 |
For institutional investors. Book with your work email.
Biodol Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| V-Bio Ventures | VC Round, Series A |
| Bpifrance | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 44% MoM, from 953 to 1.4K.
- May 18, 2026
Monthly visitors increased 548% MoM.
For institutional investors. Book with your work email.
Biodol Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biodol Therapeutics's valuation, stock price, and market status.
Is Biodol Therapeutics a public or private company?
Biodol Therapeutics is a private company.
What is the current stock price of Biodol Therapeutics?
Biodol Therapeutics is a private company, so its shares have no public market price. Caplight tracks Biodol Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biodol Therapeutics worth (valuation)?
Valuation information for Biodol Therapeutics is not publicly available.
Can I buy Biodol Therapeutics stock?
Biodol Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biodol Therapeutics's last funding round?
Biodol Therapeutics's most recent funding round was VC Round on May 21, 2024.
Who are the main investors in Biodol Therapeutics?
Key investors in Biodol Therapeutics include V-Bio Ventures.
Will Biodol Therapeutics IPO soon?
No public IPO plans have been announced for Biodol Therapeutics.
How can I track Biodol Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Biodol Therapeutics's shares on secondary markets.